eFFECTOR Therapeutics, Inc.
USD0.00
-0.00 (-0.00%)
CEO
Davide Ruggero
IPO Date
2021-03-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.00
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.00
52W Low
$0.00
52W High
$0.00
Market Cap
$0.00B
Volume
0.04M
| -1.4 |
| 31 Dec 2021 | FY | 98.3% | 1104.8% | 91.4% | 29.2% | 1.16 | 13.30 | 21.2 |
| 31 Dec 2020 | FY | 100.0% | 33.8% | 1451.6% | 85.1% | 13.24 | 1.89 | 10.5 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 214.9% | -583.7% | -1.10 | 0.23 | -0.5 |
| -0.9 |
| 30 Sept 2023 | Q3 | 0.0% | 0.0% | 209.4% | -41.2% | -5.16 | 0.82 | -1.1 |
| 30 Jun 2023 | Q2 | 0.0% | 0.0% | -324.8% | -31.1% | 7.93 | 1.09 | -1.2 |
| 31 Mar 2023 | Q1 | 0.0% | 0.0% | 208.1% | -45.7% | -4.23 | 0.78 | -0.4 |
| 31 Dec 2022 | Q4 | 0.0% | 0.0% | -237.7% | -31.8% | 5.21 | 1.12 | -0.5 |
| 30 Sept 2022 | Q3 | 0.0% | 0.0% | -82.7% | -26.1% | 1.75 | 1.42 | -0.6 |
| 30 Jun 2022 | Q2 | 99.9% | -343.9% | -35.2% | -15.9% | 1.03 | 1.79 | -2.1 |
| 31 Mar 2022 | Q1 | 0.0% | 0.0% | 12.2% | 6.2% | 0.80 | 18.38 | 14.2 |
| 31 Dec 2021 | Q4 | 99.7% | 1332.1% | 110.2% | 35.2% | 1.16 | 13.30 | 4.4 |